Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/30/2003WO2002014858A3 Method for producing and identifying appropriate effectors of target molecules using substance libraries
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003WO2001097794A8 Inhibitors of matriptase for the treatment of cancer
10/30/2003WO2001085995A3 Identification of neural defects associated with the nucleosom al assembly protein 1l2 gene
10/30/2003WO2001051054A3 Use of cyclopentenone derivatives for bone and periodontal regeneration
10/30/2003US20030204873 Generating genetically engineered herbicide resistant monocotyledons
10/30/2003US20030204863 Nav2 channel gene-deficient non-human animals
10/30/2003US20030204331 Automated sample preparation methods and devices
10/30/2003US20030204321 Efficient algorithm for PCR testing of blood samples
10/30/2003US20030204320 Neural-network-based identification, and application, of genomic information practically relevant to diverse biological and sociological problems, including susceptibility to disease
10/30/2003US20030204319 Neural-network-based identification, and application, of genomic information practically relevant to diverse biological and sociological problems, including identification of clinically relevant combinations of alleles and proteins
10/30/2003US20030204316 System for cell-based screening
10/30/2003US20030204315 System and method for carbohydrate sequence presentation, comparison and analysis
10/30/2003US20030204314 Method of biomolecule analysis using computer and the computing devices
10/30/2003US20030204313 Biosensing meter
10/30/2003US20030204108 Synthesis of 2H- and 13C- substituted dithanes
10/30/2003US20030204073 Identifying an allosteric modulator/antagonist of g-protein coupled receptors for treatment of metabolic disorders
10/30/2003US20030204072 Comprises receptor protein tyrosine kinase (rPTK) for diagnosing and treating kidney or neurodegenerative diseases
10/30/2003US20030204071 109 human secreted proteins
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204065 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders
10/30/2003US20030204055 Comprise nucleotide sequences coding polypeptide for treating and preventing inflammation, tumors and nervous system disorders; animal models; gene therapy
10/30/2003US20030204053 Comprise nucleotide sequences coding polypeptide for treating and preventing inflammation, tumors and nervous system disorders; animal models; gene therapy
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030204051 Contacting a sample with an aggregating amyloid A beta peptide to which is covalently bonded a fluorescent label and detecting the fluorescent label in association with such sample as an indication of an amyloid aggregate
10/30/2003US20030204050 Comprises polypeptide for treating arthritis, cancer, autoimmune, kidney and inflammatory disorders
10/30/2003US20030203953 Repinotan kit
10/30/2003US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes
10/30/2003US20030203864 Treatment of cancer
10/30/2003US20030203847 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules
10/30/2003US20030203840 Nucleic acid containing at least one adenine base, a guanine base, a cytosine base, and at least thymin or uracil base and nucleic acid is atleast 12 bases in length, hybridizes to sense or antisense strand of second nucleic acid
10/30/2003US20030203838 Compositions and methods for inhibiting angiogenesis
10/30/2003US20030203835 Screening for inotropic agents using fluorescence, absorption spectra, luminescence or radioactivity
10/30/2003US20030203507 Using colloidal magnetic particles to detect low antigen tumor cells
10/30/2003US20030203504 Detecting and monitoring activity of cellular or molecular species at low concentrations using diffusion systems associated with microfluidic and/or photolithograhphically devices
10/30/2003US20030203503 Method for measuring substance and testing piece
10/30/2003US20030203500 High throughput testing of fluid samples using an electric field
10/30/2003US20030203499 Threshold glucose detection in urine
10/30/2003US20030203498 For sensing blood glucose levels electrochemically
10/30/2003US20030203497 Using bioassay to monitor combinatorial library synthesis and rank products in order of their ability to bind to a target molecule which is capable of unfolding when heated
10/30/2003US20030203496 Using one step colorimetric analysis for qualitative determination of lead in lead-based paint and other media
10/30/2003US20030203495 Diagnostic test for elemental imbalances
10/30/2003US20030203486 Transfection method and uses related thereto
10/30/2003US20030203483 Differentiated mesenchymal cells for enhancing engraftment of hematopoietic progenitor cells, bone marrow transplantation or treatment and/or prevention of graft versus host disease
10/30/2003US20030203481 Miniaturized achromosomal, anucleotic, synthetic cells for use as diagnostics and drug disocovery tools in proteomics
10/30/2003US20030203469 Efficient purification of adenovirus
10/30/2003US20030203462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203452 Human chemokine beta-13
10/30/2003US20030203440 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203438 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203432 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203430 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203428 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203423 Pre-treatment kit for saliva and pre-treatment method for saliva using the same
10/30/2003US20030203421 Stabilized tetrazolium reagent compositions and methods for using the same
10/30/2003US20030203420 Cytotoxicity assay
10/30/2003US20030203419 Identifying modulators of microtubule polypeptide; antiproliferative agents
10/30/2003US20030203418 Animal models and methods for sepsis
10/30/2003US20030203416 ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
10/30/2003US20030203414 Enzyme inhibitor for treating and preventing cancer, apoptosis defects and viral infections
10/30/2003US20030203413 Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups
10/30/2003US20030203412 Immunoassay for detection of antibodies for molds and mycotoxins
10/30/2003US20030203411 Methods of minicell-based delivery
10/30/2003US20030203410 Gestational agents which modulate cell proliferation
10/30/2003US20030203407 Compositions and methods for monitoring the phosphorylation of natural binding partners
10/30/2003US20030203405 Comprises 4-(4-((acetylamino-ethylcarbamoyl-methyl)-amino)-phenyoxy)butyric acid as building blocks for solid phase synthesis; microarrays
10/30/2003US20030203404 Resonance energy transfer system to monitor protein-protein interactions; spectrum analysis
10/30/2003US20030203403 Time-resolved fluorescence assay for the detection of multimeric forms of A-beta 1-40
10/30/2003US20030203402 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203401 Comprises nucleotide sequences coding membrane protein for diagnosing, preventing and treating cell proliferative, inflammatory or tumor disorders
10/30/2003US20030203395 TCF-1 nucleotide sequence variation
10/30/2003US20030203394 Detection of a target in a sample
10/30/2003US20030203393 Using fluorescence to characterize, screen and identify mitotic cell chromosomal aberration; cancer diagnosis
10/30/2003US20030203392 Detecting sterol regulatory element binding protein (SREBP) for use in the treatment of hyperlipemia, arteriosclerosis, obesity or cancer; drug screening
10/30/2003US20030203385 Analysis of sulfated polysaccharides
10/30/2003US20030203379 Method for analyzing biomolecule
10/30/2003US20030203376 Compositions, methods and kits for determining the presence of Mycoplasma genitalium in a test sample
10/30/2003US20030203374 Assaying cells in a biological sample to distinguish between living and dead cells
10/30/2003US20030203373 Method for identifying a pharmacologically active substance
10/30/2003US20030203369 Apparatus and method for determining a signal produced by a micro array device by comparing a signal produced by an unstructured probe to a second signal produced by a structured probe
10/30/2003US20030203366 Microarray channel devices produced by a block mold process
10/30/2003US20030203365 Uses a receptor molecule such as an antibody, immobilized to a chip for a solid phase, and a sensor such as a pH electrode, an oxygen electrode or a glucose electrode for a search device
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030203360 Methods for identifying products employing gene expression
10/30/2003US20030203358 Depolymerization of a nucleic acid hybrid to qualitatively and quantitatively analyze for the presence of a predetermined exogenous nucleic acid
10/30/2003US20030203357 Detecting and differentiating viruses or other intracellular parasites present in a specimen; compositions and methods to evaluate the susceptibility of a organisms to antimicrobial agents
10/30/2003US20030203355 Preparing such binding ligands and libraries, and methods of identifying a binding ligand that specifically binds to a target molecule
10/30/2003US20030203354 Apoptosis regulators, cytoprotectants, apoptosis-inducing agents and methods of screening the same; used in prevention or treatment of nervous diseases and diseases associated with cell proliferation ; prostaglandin transporter(PGT)
10/30/2003US20030203352 Device for measuring the concentration of an analyte in, or a property of, a biological fluid such as blood and more particularly glucose in blood
10/30/2003US20030202987 Hepatitis virus; oligomer protein
10/30/2003US20030202976 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003US20030202974 Agents for the prevention of organ damage induced by therapeutic agents
10/30/2003US20030202955 Crosslinked polyether binding to protein; biodegradation
10/30/2003US20030202937 Eubacterium; membrane protein; detecting signal moderated by binding
10/30/2003US20030202906 Adding the amperage of the conductive film of the biosensor
10/30/2003US20030202904 Method for analyzing blood test sample and dry analytical element and analytical kit utilizing the method
1 ... 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 ... 3937